K. Ding et al.
FULL PAPER
13C NMR (75 MHz, CDCl3) : d=171.02, 142.36, 142.26, 138.16, 138.10,
137.99, 137.93, 133.27, 133.13, 132.98, 131.96, 131.77, 129.81, 129.76,
129.69, 129.63, 128.97, 126.19, 126.02, 59.89, 45.01, 42.46, 21.25,
13.90 ppm; IR (KBr): n=3012, 2980, 1723, 1600, 1444, 1369, 1307, 1274,
1185, 1129, 1037, 871, 850, 693, 582, 525, 423 cmÀ1; EI-MS (70 eV): m/z
(%): 257 (55), 359 (33), 360 (43), 608 (68), 746 (35), 791 (90), 792 (100),
793 (48), 864 (24); HRMS (EI): calcd for C54H58O6P2 [M+]: 864.3709;
found: 864.3733.
2980, 1722, 1605, 1586, 1509, 1477, 1464, 1435, 1369, 1328, 1303, 1266,
1216, 1159, 1134, 1093, 1070, 1035, 998, 745, 695, 546, 497, 416 cmÀ1; ele-
mental analysis calcd (%) for C46H42O4P2: C 76.65, H 5.87; found: C
76.59, H 5.93.
(À)-(S,S,S,S)-3b: Following the same procedure as described above for
the preparation of (S,S,S,S)-3a, the reduction of (S,S,S,S)-11b afforded
(S,S,S,S)-3b as an amorphous white solid (80% yield). [a]2D0 =À69.0 (c=
1
1.22 in CHCl3); H NMR (300 MHz, CDCl3, TMS): d=0.73 (t, J=7.3 Hz,
(À)-(S,S,S,S)-11 f: Following the same procedure as described above for
the preparation of (S,S,S,S)-11a, the reaction of (S,S,S,S)-10a with di(4-
tolyl)phosphine oxide afforded (S,S,S,S)-11 f as an amorphous white solid
(83% yield). [a]2D0 =À72.0 (c=1.00 in CHCl3); 1H NMR (300 MHz,
CDCl3, TMS): d=0.86 (t, J=7.3 Hz, 6H), 2.40 (s, 12H), 3.04 (d, J=
7.0 Hz, 2H), 3.73 (m, 4H), 5.38 (d, J=7.0 Hz, 2H), 6.95–7.65 (m,
6H), 3.58–3.80 (m, 18H), 5.05 (d, J=4.3 Hz, 2H), 6.63–7.25 (m,
24H) ppm; 31P NMR (121.46 MHz, CDCl3): d=À16.5 ppm; 13C N MR
(75 MHz, CDCl3): d=171.43, 160.13, 160.05, 141.18, 140.87, 138.55,
138.36, 135.85, 135.61, 135.56, 135.33, 132.00, 127.99, 127.52, 127.42,
126.83, 126.73, 126.52, 114.12, 114.01, 113.92, 59.81, 54.93, 54.88, 43.59,
42.25, 41.95, 29.46, 13.64 ppm; IR (KBr): n=3055, 2836, 1722, 1594, 1568,
1498, 1463, 1441, 1369, 1305, 1286, 1248, 1177, 1135, 1095, 1031, 827, 797,
752, 531, 501, 419 cmÀ1; ESI-MS [M++H]: 841.5; HRMS (FT): calcd for
C50H51O8P2 [M++H]: 841.3053; found: 841.3033.
24H) ppm; 31P NMR (121.46 MHz, CDCl3): d=12.7 ppm; 13C
N MR
(75 MHz, CDCl3): d=171.25, 142.57, 142.47, 141.97, 141.93, 141.87,
133.20, 133.12, 132.95, 132.25, 132.12, 131.84, 130.44, 130.30, 129.22,
129.14, 129.05, 128.90, 126.14, 125.97, 59.97, 44.81, 42.37, 42.29, 29.64,
21.59, 13.87, 0.97 ppm; IR (KBr): n=2962, 2925, 2854, 1724, 1602, 1500,
1444, 1399, 1369, 1309, 1262, 1216, 1184, 1114, 1099, 1036, 807, 756, 725,
659, 634, 620, 545, 524, 459 cmÀ1; EI-MS (70 eV): m/z (%): 91 (43), 226
(67), 229 (100), 245 (84), 331 (35), 579 (41), 688(29), 735 (66), 808 (12);
HRMS (EI): calcd for C50H50O6P2 [M+]: 808.3083; found: 808.3085.
(À)-(S,S,S,S)-3c: Following the same procedure as described above for
the preparation of (S,S,S,S)-3a, the reduction of (S,S,S,S)-11c afforded
(S,S,S,S)-3c as an amorphous white solid (91% yield). [a]2D0 =À67.8 (c=
1
0.99 in CHCl3); H NMR (300 MHz, CDCl3, TMS): d=0.75 (t, J=6.7 Hz,
6H), 1.31 (s, 18H), 1.33 (s, 18H), 3.65–3.76 (m, 4H), 3.82 (d, J=4.3 Hz,
2H), 5.18 (d, J=4.3 Hz, 2H), 6.72–7.69 (m, 24H) ppm; 31P
N MR
(121.46 MHz, CDCl3): d=À15.9 ppm; 13C NMR (75 MHz, CDCl3): d=
171.70, 151.64, 151.56, 141.85, 141.52, 138.17, 137.99, 134.25, 133.98,
133.93, 133.67, 133.27, 133.14, 132.85, 132.73, 128.26, 126.86, 126.56,
126.53, 125.51, 125.41, 125.34, 59.99, 43.84, 43.78, 42.42, 42.12, 34.63,
34.60, 31.31, 31.24, 13.83 ppm; IR (KBr): n=2964, 2904, 2869, 1725, 1600,
1510, 1494, 1463, 1393, 1365, 1331, 1305, 1268, 1142, 1094, 1084, 1037,
1016, 923, 827, 752, 592, 560 cmÀ1; ESI-MS [M++H]: 945.8; HRMS (FT)
calcd for C62H75O4P2 [M++H]: 945.5135; found: 945.5138.
(À)-(S,S,S,S)-11g: Following the same procedure as described above for
the preparation of (S,S,S,S)-11a, the reaction of (S,S,S,S)-10b with diphe-
nylphosphine oxide afforded (S,S,S,S)-11g as an amorphous white solid
(98% yield). [a]2D0 =À50.0 (c=1.06 in CHCl3); 1H NMR (300 MHz,
CDCl3, TMS): d=2.95 (d, J=9.0 Hz, 2H), 3.23 (s, 6H), 5.33 (d, J=
8.7 Hz, 2H), 6.91–7.75 (m, 28H) ppm; 31P NMR (121.46 MHz, CDCl3):
d=31.5 ppm; 13C NMR (75 MHz, CDCl3): d=171.50, 142.27, 142.18,
133.28, 133.20, 133.14, 133.02, 132.73, 132.31, 132.28, 132.22, 132.17,
132.09, 132.04, 131.91, 131.75, 131.71, 131.64, 131.60, 131.37, 128.93,
128.80, 128.54, 128.51, 128.38, 128.35, 126.39, 126.22, 51.15, 45.14, 42.39,
42.32 ppm; IR (KBr): n=1728, 1437, 1189, 1135, 1117, 1100, 751, 721,
696, 553, 514 cmÀ1; ESI-MS [M++H]: 825.2; HRMS (FT): calcd for
C44H38O6P2N a [M++Na]: 747.2036; found: 747.2044.
(À)-(S,S,S,S)-3d: Following the same procedure as described above for
the preparation of (S,S,S,S)-3a, the reduction of (S,S,S,S)-11d afforded
(S,S,S,S)-3d as an amorphous white solid (76% yield). [a]2D0 =À70.6 (c=
1
1.04 in CHCl3); H NMR (300 MHz, CDCl3, TMS): d=0.77 (t, J=6.7 Hz,
6H), 2.31 (s, 6H), 2.32 (s, 6H), 3.67–3.79 (m, 6H), 5.18 (d, J=4.3 Hz,
2H), 6.76–7.51 (m, 24H) ppm; 31P NMR (121.46 MHz, CDCl3): d=
À13.2 ppm; 13C NMR (75 MHz, CDCl3): d=171.45, 141.71, 141.38,
137.91, 137.81, 137.76, 137.65, 137.57, 137.38, 136.41, 136.26, 135.90,
135.77, 135.08, 134.77, 134.45, 132.64, 131.52, 131.28, 131.06, 130.84,
129.39, 129.41, 128.98, 128.37, 128.25, 128.14, 126.87, 126.50, 59.90, 43.87,
42.50, 42.18, 21.30, 13.65 ppm; IR (KBr): n=3422, 3056, 2980, 2925, 2870,
1721, 1592, 1489, 1477, 1444, 1405, 1370, 1332, 1307, 1246, 1219, 1174,
1136, 1114, 1036, 998, 925, 872, 784, 758, 697, 566, 559, 464 cmÀ1; ESI-MS
[M++H]: 777.5; HRMS (ESI) calcd for C50H51O4P2 [M++H]: 777.3263;
found: 777.3235.
(À)-(S,S,S,S)-11h: Following the same procedure as described above for
the preparation of (S,S,S,S)-11a, the reaction of (S,S,S,S)-10c with diphe-
nylphosphine oxide afforded a mixture of the by-product BnP(O)Ph2 and
(S,S,S,S)-11h. Isolation of the desired pure (S,S,S,S)-11h proved to be
very difficult. The mixture was directly used in subsequent reduction to
(À)-(S,S,S,S)-3h without further purification (see synthesis of (À)-
(S,S,S,S)-3h) To get an unambiguous identification of compound
(S,S,S,S)-11h, however, its pure form was obtained in quantitative yield
by oxidation of (À)-(S,S,S,S)-3h with 30% H2O2 in THF. The spectros-
copic data are as follows: [a]2D0 =À75.8 (c=1.01 in CHCl3); 1H N MR
(300 MHz, CDCl3, TMS): d=3.05 (d, J=8.7 Hz, 2H), 4.43 (d, J=8.4 Hz,
2H), 4.57 (d, J=12.3 Hz, 2H), 4.74 (d, J=12.3 Hz, 2H), 6.90–7.70 (m,
(À)-(S,S,S,S)-3e: Following the same procedure as described above for
the preparation of (S,S,S,S)-3a, the reduction of (S,S,S,S)-11e afforded
(S,S,S,S)-3e as an amorphous white solid (74% yield). [a]2D0 =À131.9 (c=
38H) ppm; 31P NMR (121.46 MHz, CDCl3): d=31.3 ppm; 13C
N MR
(75 MHz, CDCl3): d=170.11, 141.39, 141.28, 134.40, 132.22, 132.14,
132.11, 131.44, 131.27, 131.24, 131.14, 131.10, 130.73, 130.60, 128.11,
127.98, 127.55, 127.50, 127.38, 127.34, 127.21, 127.02, 125.47, 125.31, 65.37,
43.73, 41.53, 41.45, 28.67 ppm; IR (KBr): n=1723, 1438, 1306, 1262, 1186,
1
1.01 in CHCl3); H NMR (300 MHz, CDCl3, TMS): d=0.70 (t, J=6.7 Hz,
6H), 2.16 (s, 12H), 2.20 (s, 12H), 3.66 (m, 6H), 5.25 (d, J=4.2 Hz, 2H),
6.60–7.00 (m, 20H); 31P NMR (121.46 MHz, CDCl3): d=À12.5 ppm; IR
(KBr): n=3396, 2980, 2921, 2862, 1723, 1600, 1467, 1444, 1370, 1307,
1160, 1134, 1116, 1100, 1071, 1027, 752, 722, 695, 553, 513 cmÀ1; ESI-MS
1274, 1182, 1130, 1073, 1037, 872, 851, 757, 723, 693, 581, 525, 468 cmÀ1
;
+
[M++H]: 877.3; HRMS (FT): calcd for C56H46O6P2N
a
[M+Na]:
EI-MS (70 eV): m/z (%): 343 (14), 416 (8), 555 (23), 591 (100), 592 (30),
593 (9), 727 (8), 759 (10); elemental analysis calcd (%) for C54H58O4P2: C
77.86, H 7.02; found: C 77.66, H 7.18.
899.2662; found: 899.2667.
(À)-(S,S,S,S)-3a: HSiCl3 (2.85 mL, 25.0 mmol) was added to a solution of
(S,S,S,S)-11a (0.752 g, 1.0 mmol) and PhNMe2 (7.2 mL, 25.0 mmol) in
dried toluene (8 mL) at 08C. The reaction mixture was stirred for 0.5 h,
and then heated at 1008C with stirring for an additional 12 h. The reac-
tion was quenched at room temperature with concentrated aqueous
NaHCO3. The mixture was filtered through Celite, and the filtrate was
extracted with diethyl ether, washed with water and brine. The organic
phase was dried over Na2SO4, filtered and concentrated under reduced
pressure. The residue was submitted to chromatographic separation on
silica gel using hexane/EtOAc (10:1) as eluent to give an amorphous
white solid (0.53 g, 74%). [a]2D0 =À111.2 (c=1.00 in CHCl3); 1H N MR
(300 MHz, CDCl3, TMS): d=0.77 (t, J=7.2 Hz, 6H), 3.72 (m, 6H), 5.21
(d, J=3.3 Hz, 2H), 6.70–7.40 (m, 28H) ppm; 31P NMR (121.46 MHz,
CDCl3): d=À13.2 ppm; EI-MS (70 eV): m/z (%): 183 (12), 201 (19), 287
(23), 471 (11), 535 (100), 536 (26), 563 (9), 580 (9); IR (KBr): n=3053,
(À)-(S,S,S,S)-3 f: Following the same procedure as described above for
the preparation of (S,S,S,S)-3a, the reduction of (S,S,S,S)-11 f afforded
(S,S,S,S)-3 f as an amorphous white solid (76% yield). [a]2D0 =À76.4 (c=
1
0.75 in CHCl3); H NMR (300 MHz, CDCl3, TMS): d=0.79 (t, J=9.2 Hz,
6H), 2.38 (s, 6H), 2.35 (s, 6H), 3.66–3.80 (m, 6H), 5.17 (d, J=3.6 Hz,
2H), 6.71–7.29 (m, 24H) ppm; 31P NMR (121.46 MHz, CDCl3): d=
À15.2 ppm; 13C NMR (75 MHz, CDCl3): d=171.67, 141.71, 141.38,
138.56, 138.07, 137.88, 134.54, 134.27, 133.99, 133.36, 133.24, 132.76,
132.64, 132.54, 129.37, 129.28, 129.18, 128.24, 126.87, 126.71, 126.64, 60.03,
43.87, 43.82, 42.48, 42.17, 29.67, 21.34, 13.76 ppm; IR (KBr): n=2958,
2924, 2854, 1723, 1497, 1463, 1441, 1369, 1304, 1215, 1186, 1160, 1093,
1036, 806, 750, 628, 508 cmÀ1; ESI-MS [M++H]: 777.5; HRMS (FT) calcd
for C50H51O4P2 [M++H]: 777.3263; found: 777.3257.
5960
ꢁ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 5952 – 5963